Richard H Goldin, MD in Torrance, CA - Internal Medicine

Richard H Goldin, MD is a Internal Medicine - Rheumatology physician based in Torrance, California. Richard H Goldin is licensed to practice in California (license number GA23022) and his current practice location is 23441 Madison St, Suite #340, Torrance, California. He can be reached at his office (for appointments etc.) via phone at (310) 373-0340.

NPI number for Richard H Goldin is 1124034103 and his current mailing address is 23441 Madison St, Suite #340, Torrance, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1124034103.

Contact Information

	Richard H Goldin, MD
	23441 Madison St, Suite #340, Torrance, CA 90505-4725
	(310) 373-0340
	(310) 373-7142

Physician's Profile

Full Name	Richard H Goldin
Gender	Male
Speciality	Internal Medicine - Rheumatology
Location	23441 Madison St, Torrance, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1124034103
Provider Enumeration Date: 07/31/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Richard H Goldin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1124034103	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RR0500X	Internal Medicine - Rheumatology	GA23022 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Richard H Goldin is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Richard H Goldin, MD 23441 Madison St, Suite #340, Torrance, CA 90505-4725 Ph: (310) 373-0340	Richard H Goldin, MD 23441 Madison St, Suite #340, Torrance, CA 90505-4725 Ph: (310) 373-0340

News Archive

Neoprobe achieves accrual goal in Lymphoseek Phase 3 study in breast cancer/melanoma

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that a multi-center Phase 3 study of Lymphoseek® has enrolled clinical subjects to achieve the minimum analysis goal of 196 lymph nodes, the study's primary accrual objective.

Arrowhead receives approval to initiate Phase 2a clinical trial of ARC-520 for chronic HBV infection

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received regulatory approval to begin a Phase 2a clinical trial of ARC-520, its RNAi-based drug candidate for the treatment of chronic hepatitis B virus (HBV) infection.

Fondation Leducq awards Penn Medicine researcher $6M grant for cardiovascular disease study

An international team of researchers led by Daniel J. Rader, MD, associate director of Penn Medicine's Institute for Translational Medicine and Therapeutics, has received a $6 million grant from the Paris-based Fondation Leducq to study the molecular genetics of atherosclerotic cardiovascular disease. The team's proposal, "Molecular Mechanisms of Novel Genes Associated with Plasma Lipids and Cardiovascular Disease," was selected to receive the award through the Fondation's Transatlantic Networks of Excellence Program.

Green plants in city streets can effectively reduce levels of air pollutants

Trees, bushes and other greenery growing in the concrete-and-glass canyons of cities can reduce levels of two of the most worrisome air pollutants by eight times more than previously believed, a new study has found. A report on the research appears in the ACS journal Environmental Science & Technology.

DePuy Synthes knee system shown to be beneficial for economics and patient reported outcomes

DePuy Synthes*, part of the Johnson & Johnson Family of Companies, released a new report, "Improving the Value of Primary Total Knee Arthroplasty: the ATTUNE® Knee System," that analyzes the ATTUNE Knee's current clinical and economic data. The report concludes that in a value-based healthcare environment with cost constraints and growing procedure volumes, the value of a knee replacement implant is measured not only by how long the implant lasts (implant survivorship), but also through patient reported outcomes and the economic benefits of the procedure.

Internal Medicine Doctors in Torrance, CA

Deborah Chon, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 100, Torrance, CA 90505 Phone: 310-542-6333
Erika Joyce Kalash, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811
Hosayn Khaleeli, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2245 Sepulveda Blvd, Torrance, CA 90501 Phone: 310-320-3204 Fax: 310-320-0919
Mr. Anthony C Dike, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 20280 S Vermont Ave Ste 215, Torrance, CA 90502 Phone: 323-434-4626 Fax: 310-693-8082
Paul J Brown, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3333 Skypark Dr, Torrance, CA 90505 Phone: 310-517-9006
Dr. Philip W Chung, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2841 Lomita Blvd 215, Torrance, CA 90505 Phone: 310-379-2860 Fax: 310-325-1144
Dr. Diane Jennifer Prager, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 300, Torrance, CA 90505 Phone: 310-325-8252

Richard H Goldin, MD - Internal Medicine in Torrance, CA